Table 4 PROMIS domains measuring different aspects of health-related quality of life at follow-up between participants with and without SARS-CoV-2 infection
PROMIS domains | Infection at baseline (n = 350) | No infection (n = 4467) | ||||
|---|---|---|---|---|---|---|
n | mean score (95% CI) | β coefficient (95% CI) | n | mean score (95% CI)) | β coefficient (95% CI) | |
Physical functioning a | 347 | 52.7 (52.0–53.5) | -0,92 (-1.51- -0.33) | 4434 | 53.3 (53.2–53.6) | reference |
Anxiety symptoms b | 347 | 48.9 (48.0–49.7) | 0.37 (-0.45–1.19) | 4429 | 48.6 (48.3–48.8) | reference |
Depressive symptoms b | 347 | 49.3 (48.5–50.1) | 0.74 (-0.06–1.54) | 4430 | 48.6 (48.4–48.9) | reference |
Fatigue b | 347 | 47.4 (46.3–48.4) | 1.44 (0.44–2.43) | 4430 | 46.3 (46.0–46.6) | reference |
Sleep disturbance b | 347 | 47.5 (46.7–48.4) | 0.21 (-0.66–1.08) | 4424 | 47.5 (47.2–47.7) | reference |
Ability to participate in social roles/activities a | 345 | 54.2 (53.3–55.2) | 0.52 (-0.40–1.43) | 4415 | 53.5 (53.3–53.8) | reference |
Pain interference b | 346 | 48.6 (47.7–49.4) | 0.19 (-0.61–1.00) | 4419 | 48.5 (48.2–48.7) | reference |
Pain intensity b | 345 | 1.87 (1.65–2.10) | 0.08 (-0.12–0.28) | 4412 | 1.79 (1.73–1.85) | reference |